Synergistic deterioration of prognosis associated with decreased grip strength and hyporesponse to erythropoiesis-stimulating agents in patients undergoing hemodialysis-Reference-Cited by-同舟云学术

Synergistic deterioration of prognosis associated with decreased grip strength and hyporesponse to erythropoiesis-stimulating agents in patients undergoing hemodialysis

Published:2022-10-28 Issue:1 Volume:44 Page:1811-1820
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Kobayashi Shizuka¹,Tanaka Kentaro²,Hoshino Junichi³,Hara Shigeko⁴,Kushiyama Akifumi⁵,Tanaka Yoshihide⁶,Motonishi Shuta⁷,Sakai Ken⁸,Ozawa Takashi¹

Affiliation:

1. Internal Medicine, Kodaira Kitaguchi Clinic, Tokyo, Japan

2. Internal Medicine, Higashikurume Ekimae Clinic, Tokyo, Japan

3. Nephrology Center, Toranomon Hospital, Tokyo, Japan

4. Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan

5. Department of Pharmacotherapy, Meiji Pharmaceutical University, Tokyo, Japan

6. Internal Medicine, Kumegawa Touseki Naika Clinic, Tokyo, Japan

7. Internal Medicine, Higashiyamato Nangai Clinic, Tokyo, Japan

8. Department of Nephrology, Faculty of Medicine, Toho University, Tokyo, Japan

Funder

Okinaka Memorial Institute for Medical Research

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2022.2106873

Reference29 articles.

1. Excerpts from the United States Renal Data System 2004 Annual Data Report: Atlas of end-stage renal disease in the United States

2. Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations

3. Relationship between anaemia management at haemodialysis initiation and patient prognosis

4. Erythropoietin Resistance Index and the All-Cause Mortality of Chronic Hemodialysis Patients

5. Relationship between anti-erythropoietin receptor autoantibodies and responsiveness to erythropoiesis-stimulating agents in patients on hemodialysis: a multi-center cross-sectional study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influencing factors of the erythropoietin resistance index and its association with all-cause mortality in maintenance hemodialysis patients;Renal Failure;2024-01-17

2. The Association between High-Dose Allopurinol and Erythropoietin Hyporesponsiveness in Advanced Chronic Kidney Disease: JOINT-KD Study;Nephron;2024

3. Investigating the relationship between erythropoiesis-stimulating agents and mortality in hemodialysis patients: A systematic review and meta-analysis;PLOS ONE;2023-11-09